70 related articles for article (PubMed ID: 22571483)
21. GSK3β Inhibition Prevents Macrophage Reprogramming by High-Dose Methotrexate.
Ríos I; López-Navarro B; Torres-Torresano M; Soler Palacios B; Simón-Fuentes M; Domínguez-Soto Á; Muller IB; Jansen G; Corbí ÁL; Puig-Kröger A
J Innate Immun; 2023; 15(1):283-296. PubMed ID: 36380627
[TBL] [Abstract][Full Text] [Related]
22. Pharmacogenomics in Cytotoxic Chemotherapy of Cancer.
Talebi Z; Sparreboom A; Colace SI
Methods Mol Biol; 2022; 2547():63-94. PubMed ID: 36068461
[TBL] [Abstract][Full Text] [Related]
23. Impact of Variants in the
Cereja Pantoja KBC; Azevedo TCB; Carvalho DC; Monte N; Cohen Paes AN; Barros MCDC; Vinagre LWMS; Freitas ARS; Burbano RMR; Assumpção PP; Santos SEBD; Fernandes MR; Santos NPCD
Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205374
[TBL] [Abstract][Full Text] [Related]
24. Insights on Metabolic Reprogramming and Its Therapeutic Potential in Acute Leukemia.
Di Martino L; Tosello V; Peroni E; Piovan E
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445444
[TBL] [Abstract][Full Text] [Related]
25. Glutamic Acid Increased Methotrexate Polyglutamation and Cytotoxicity in a CCRF-SB Acute Lymphoblastic Leukemia Cell Line.
Mendoza-Santiago A; Becerra E; Garay E; Bah M; Berumen-Segura L; Escobar-Cabrera J; Hernández-Pérez A; García-Alcocer G
Medicina (Kaunas); 2019 Nov; 55(12):. PubMed ID: 31779260
[No Abstract] [Full Text] [Related]
26. Deregulation of folate pathway gene expression correlates with poor prognosis in acute leukemia.
Organista-Nava J; Gómez-Gómez Y; Del Moral-Hernandez O; Illades-Aguiar B; Gómez-Santamaria J; Rivera-Ramírez AB; Saavedra-Herrera MV; Jimenez-López MA; Leyva-Vázquez MA
Oncol Lett; 2019 Sep; 18(3):3115-3127. PubMed ID: 31452789
[TBL] [Abstract][Full Text] [Related]
27. Gene-Based Dose Optimization in Children.
Ramsey LB; Brown JT; Vear SI; Bishop JR; Van Driest SL
Annu Rev Pharmacol Toxicol; 2020 Jan; 60():311-331. PubMed ID: 31283429
[TBL] [Abstract][Full Text] [Related]
28. Ginger extract has anti-leukemia and anti-drug resistant effects on malignant cells.
Rahimi Babasheikhali S; Rahgozar S; Mohammadi M
J Cancer Res Clin Oncol; 2019 Aug; 145(8):1987-1998. PubMed ID: 31214760
[TBL] [Abstract][Full Text] [Related]
29. Dietary polyphenols influence antimetabolite agents: methotrexate, 6-mercaptopurine and 5-fluorouracil in leukemia cell lines.
Mahbub A; Le Maitre C; Haywood-Small S; Cross N; Jordan-Mahy N
Oncotarget; 2017 Dec; 8(62):104877-104893. PubMed ID: 29285220
[TBL] [Abstract][Full Text] [Related]
30. Anti-tumor Study of Chondroitin Sulfate-Methotrexate Nanogels.
Wang J; Zhao W; Chen H; Qin A; Zhu P
Nanoscale Res Lett; 2017 Oct; 12(1):572. PubMed ID: 29067569
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia promotes chemoresistance in acute lymphoblastic leukemia cell lines by modulating death signaling pathways.
Petit C; Gouel F; Dubus I; Heuclin C; Roget K; Vannier JP
BMC Cancer; 2016 Sep; 16(1):746. PubMed ID: 27658583
[TBL] [Abstract][Full Text] [Related]
32. Association of SLCO1B1 gene polymorphisms with toxicity response of high dose methotrexate chemotherapy in childhood acute lymphoblastic leukemia.
Li J; Wang XR; Zhai XW; Wang HS; Qian XW; Miao H; Zhu XH
Int J Clin Exp Med; 2015; 8(4):6109-13. PubMed ID: 26131212
[TBL] [Abstract][Full Text] [Related]
33. Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.
Kelemen LE; Terry KL; Goodman MT; Webb PM; Bandera EV; McGuire V; Rossing MA; Wang Q; Dicks E; Tyrer JP; Song H; Kupryjanczyk J; Dansonka-Mieszkowska A; Plisiecka-Halasa J; Timorek A; Menon U; Gentry-Maharaj A; Gayther SA; Ramus SJ; Narod SA; Risch HA; McLaughlin JR; Siddiqui N; Glasspool R; Paul J; Carty K; Gronwald J; Lubiński J; Jakubowska A; Cybulski C; Kiemeney LA; Massuger LF; van Altena AM; Aben KK; Olson SH; Orlow I; Cramer DW; Levine DA; Bisogna M; Giles GG; Southey MC; Bruinsma F; Kjaer SK; Høgdall E; Jensen A; Høgdall CK; Lundvall L; Engelholm SA; Heitz F; du Bois A; Harter P; Schwaab I; Butzow R; Nevanlinna H; Pelttari LM; Leminen A; Thompson PJ; Lurie G; Wilkens LR; Lambrechts D; Van Nieuwenhuysen E; Lambrechts S; Vergote I; Beesley J; ; Fasching PA; Beckmann MW; Hein A; Ekici AB; Doherty JA; Wu AH; Pearce CL; Pike MC; Stram D; Chang-Claude J; Rudolph A; Dörk T; Dürst M; Hillemanns P; Runnebaum IB; Bogdanova N; Antonenkova N; Odunsi K; Edwards RP; Kelley JL; Modugno F; Ness RB; Karlan BY; Walsh C; Lester J; Orsulic S; Fridley BL; Vierkant RA; Cunningham JM; Wu X; Lu K; Liang D; Hildebrandt MA; Weber RP; Iversen ES; Tworoger SS; Poole EM; Salvesen HB; Krakstad C; Bjorge L; Tangen IL; Pejovic T; Bean Y; Kellar M; Wentzensen N; Brinton LA; Lissowska J; Garcia-Closas M; Campbell IG; Eccles D; Whittemore AS; Sieh W; Rothstein JH; Anton-Culver H; Ziogas A; Phelan CM; Moysich KB; Goode EL; Schildkraut JM; Berchuck A; Pharoah PD; Sellers TA; Brooks-Wilson A; Cook LS; Le ND
Mol Nutr Food Res; 2014 Oct; 58(10):2023-35. PubMed ID: 25066213
[TBL] [Abstract][Full Text] [Related]
34. Role of methamphetamine on glioblastoma cytotoxicity induced by doxorubicin and methotrexate.
Capelôa T; Caramelo F; Fontes-Ribeiro C; Gomes C; Silva AP
Neurotox Res; 2014 Oct; 26(3):216-27. PubMed ID: 24652521
[TBL] [Abstract][Full Text] [Related]
35. Association of ABCC2 -24C>T polymorphism with high-dose methotrexate plasma concentrations and toxicities in childhood acute lymphoblastic leukemia.
Liu Y; Yin Y; Sheng Q; Lu X; Wang F; Lin Z; Tian H; Xu A; Zhang J
PLoS One; 2014; 9(1):e82681. PubMed ID: 24404132
[TBL] [Abstract][Full Text] [Related]
36. Intracellular disposition of methotrexate in acute lymphoblastic leukemia in children.
de Beaumais TA; Jacqz-Aigrain E
Curr Drug Metab; 2012 Jul; 13(6):822-34. PubMed ID: 22571483
[TBL] [Abstract][Full Text] [Related]
37. Modeling mechanisms of in vivo variability in methotrexate accumulation and folate pathway inhibition in acute lymphoblastic leukemia cells.
Panetta JC; Sparreboom A; Pui CH; Relling MV; Evans WE
PLoS Comput Biol; 2010 Dec; 6(12):e1001019. PubMed ID: 21152005
[TBL] [Abstract][Full Text] [Related]
38. A mathematical model of in vivo methotrexate accumulation in acute lymphoblastic leukemia.
Panetta JC; Yanishevski Y; Pui CH; Sandlund JT; Rubnitz J; Rivera GK; Ribeiro R; Evans WE; Relling MV
Cancer Chemother Pharmacol; 2002 Nov; 50(5):419-28. PubMed ID: 12439601
[TBL] [Abstract][Full Text] [Related]
39. The interaction of 6-mercaptopurine (6-MP) and methotrexate (MTX).
Giverhaug T; Loennechen T; Aarbakke J
Gen Pharmacol; 1999 Oct; 33(4):341-6. PubMed ID: 10523073
[TBL] [Abstract][Full Text] [Related]
40. Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis.
Dervieux T; Furst D; Lein DO; Capps R; Smith K; Walsh M; Kremer J
Arthritis Rheum; 2004 Sep; 50(9):2766-74. PubMed ID: 15457444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
